Daniel Patrick O'Day, Chairman & CEO: Gilead Sciences GILD Planned sale · Filed 03/27

Trade details

Type: Planned sale notice
Stock: Gilead Sciences GILD
Person: Daniel Patrick O'DayChairman & CEO
Planned sale date: 26/03/27
Filed: 26/03/27

More to sell after $37.1M in 3 months

Gilead Sciences trades, last 26 weeks

What else happened in Gilead Sciences around then

Filed or reported within 30 days of the trade day · 02/25~04/26

Daniel Patrick O'Day's recent trades

Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.8M
12,000 sh
$1.8M
Filed 10/02
Traded 10/01
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$445.9K
3,000 sh
$445.9K
Filed 10/02
Traded 10/01
Daniel Patrick O'DayChairman & CEO
Planned sale10b5-1 planGilead Sciences
Planned sale10b5-1 plan
Gilead Sciences
GILD
$7.2M
55,000 sh
$7.2M
Filed 08/03
Traded 08/03
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$1.4M
10,900 sh
$1.4M
Filed 06/02
Traded 06/01
Daniel Patrick O'DayChairman & CEO
Sell10b5-1 planGilead Sciences
Sell10b5-1 plan
Gilead Sciences
GILD
$404.9K
3,062 sh
$404.9K
Filed 06/02
Traded 06/01

Daniel Patrick O'Day, Chairman — plans to sell 10,000 sh of Gilead Sciences GILD · $1.4M · around 03/27 · 10b5-1 plan | Whalegun